Concinnity Genetics raises £3m to establish unique RNA-based control systems for precise control of gene therapies in oversubscribed round

Concinnity Genetics, an Edinburgh-based gene control company, is thrilled to announce the closure of its oversubscribed £3m seed funding round. The investment was led by Eos Advisory with support from Scottish Enterprise, Old College Capital (OCC) - the University of Edinburgh’s in-house venture investment fund, and Maven Capital Partners.

Read More
Member NewsValerie Evans
Carbogenics Secures Nearly Half a Million Pounds to Drive Global Growth

University of Edinburgh spinout Carbogenics, a leading innovator in sustainable biochar technology, is thrilled to announce the successful close of its latest funding round, securing just under half a million pounds. This significant milestone reflects the confidence of both existing and new investors in Carbogenics’ mission to revolutionise sustainable solutions and expand its global footprint.

Read More
Member NewsValerie Evans
A3 Scotland Conference Highlights

In October, IBioIC had the pleasure to sponsor and participate in the 2nd annual A3 Scotland conference hosted in Inverness, jointly organised by HIE and SRUC. This event brought together around 200 industry leaders, innovators, and experts to discuss key topics shaping our sector. In this post, our IBioIC Senior Business Engagement managers, Annelie & Caroline, reflect on their time at the conference.

Read More
Blog, Event NewsSophie Stewart
Lab-based “gut” model to help study of health-promoting bacteria being developed by NCIMB and The Rowett Institute in new KTP project

Aberdeen-based biotechnology company NCIMB is collaborating with the pioneering Rowett Institute to develop a tool that will improve understanding of microbes that have important roles in human health and disease, and support development of new treatments for inflammatory bowel disease, liver disease and cancer. The work has received funding from Innovate UK.

Read More
Member NewsValerie Evans